申请人:CANCER THERAPEUTICS CRC PTY LTD
公开号:WO2014027199A1
公开(公告)日:2014-02-20
The use of a compound of the formula (I): (Formula (I)) in the preparation of a medicament for treating Acute Myeloid Leukemia or a disease ameliorated by the inhibition of Flt3, or Flt3 and FAK.
使用公式(I)的化合物:(公式(I))在制备用于治疗急性髓系白血病或通过抑制Flt3、或Flt3和FAK得到改善的疾病的药物中的应用。